Dexamethasone potentiates the antiangiogenic activity of docetaxel in castration-resistant prostate cancer

por Wilson, C, Scullin, P, Worthington, J, Seaton, A, Maxwell, P, O'Rourke, D, Johnston, P G, McKeown, S R, Wilson, R H, O'Sullivan, J M, Waugh, D J J
Publicado 2008

Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin's lymphoma: a population-based case–control study

por Jensen, A Ø, Thomsen, H F, Engebjerg, M C, Olesen, A B, Friis, S, Karagas, M R, Sørensen, H T
Publicado 2009

Expression of uPAR mRNA in peripheral blood is a favourite marker for metastasis in gastric cancer cases

por Kita, Y, Fukagawa, T, Mimori, K, Kosaka, Y, Ishikawa, K, Aikou, T, Natsugoe, S, Sasako, M, Mori, M
Publicado 2009

Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients

por Ruiz, M I Galleges, Floor, K, Steinberg, S M, Grünberg, K, Thunnissen, F B J M, Belien, J A M, Meijer, G A, Peters, G J, Smit, E F, Rodriguez, J A, Giaccone, G
Publicado 2009

The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer

por Deans, D A C, Tan, B H, Wigmore, S J, Ross, J A, de Beaux, A C, Paterson-Brown, S, Fearon, K C H
Publicado 2009

LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model

por Fuh, B, Sobo, M, Cen, L, Josiah, D, Hutzen, B, Cisek, K, Bhasin, D, Regan, N, Lin, L, Chan, C, Caldas, H, DeAngelis, S, Li, C, Li, P-K, Lin, J
Publicado 2009

A phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer

por Michael, M, Price, T, Ngan, S Y, Ganju, V, Strickland, A H, Muller, A, Khamly, K, Milner, A D, Dilulio, J, Matera, A, Zalcberg, J R, Leong, T
Publicado 2009

Recognition of skin malignancy by general practitioners: observational study using data from a population-based randomised controlled trial

por Pockney, P, Primrose, J, George, S, Jayatilleke, N, Leppard, B, Smith, H, Little, P, Kneebone, R, Lowy, A
Publicado 2009

Incidence and survival of childhood bone cancer in northern England and the West Midlands, 1981–2002

por Eyre, R, Feltbower, R G, Mubwandarikwa, E, Jenkinson, H C, Parkes, S, Birch, J M, Eden, T O B, James, P W, McKinney, P A, Pearce, M S, McNally, R J Q
Publicado 2009

Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer

por Han, S-W, Oh, D-Y, Im, S-A, Park, S R, Lee, K-W, Song, H S, Lee, N-S, Lee, K H, Choi, I S, Lee, M H, Kim, M A, Kim, W H, Bang, Y-J, Kim, T-Y
Publicado 2009

Nuclear oxidative damage correlates with poor survival in colorectal cancer

por Sheridan, J, Wang, L-M, Tosetto, M, Sheahan, K, Hyland, J, Fennelly, D, O'Donoghue, D, Mulcahy, H, O'Sullivan, J
Publicado 2009

Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening?

por Grazzini, G, Visioli, C B, Zorzi, M, Ciatto, S, Banovich, F, Bonanomi, A G, Bortoli, A, Castiglione, G, Cazzola, L, Confortini, M, Mantellini, P, Rubeca, T, Zappa, M
Publicado 2009

Cross talk between hedgehog and epithelial–mesenchymal transition pathways in gastric pit cells and in diffuse-type gastric cancers

por Ohta, H, Aoyagi, K, Fukaya, M, Danjoh, I, Ohta, A, Isohata, N, Saeki, N, Taniguchi, H, Sakamoto, H, Shimoda, T, Tani, T, Yoshida, T, Sasaki, H
Publicado 2009

Deficient mismatch repair system in patients with sporadic advanced colorectal cancer

por Koopman, M, Kortman, G A M, Mekenkamp, L, Ligtenberg, M J L, Hoogerbrugge, N, Antonini, N F, Punt, C J A, van Krieken, J H J M
Publicado 2009

A randomised pilot Phase II study of doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC) given 2 weekly with pegfilgrastim (accelerated) vs 3 weekly (stan...

por Jones, R L, Walsh, G, Ashley, S, Chua, S, Agarwal, R, O'Brien, M, Johnston, S, Smith, I E
Publicado 2009

Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case–control study

por Gadalla, S M, Amr, S, Langenberg, P, Baumgarten, M, Davidson, W F, Schairer, C, Engels, E A, Pfeiffer, R M, Goedert, J J
Publicado 2009

DLEC1 is a functional 3p22.3 tumour suppressor silenced by promoter CpG methylation in colon and gastric cancers

por Ying, J, Poon, F F, Yu, J, Geng, H, Wong, A H Y, Qiu, G-H, Goh, H K, Rha, S Y, Tian, L, Chan, A T C, Sung, J J Y, Tao, Q
Publicado 2009

Effect of portal vein embolisation on the growth rate of colorectal liver metastases

por Pamecha, V, Levene, A, Grillo, F, Woodward, N, Dhillon, A, Davidson, B R
Publicado 2009

Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group

por Ray-Coquard, I, Weber, B, Cretin, J, Haddad-Guichard, Z, Lévy, E, Hardy-Bessard, A C, Gouttebel, M C, Geay, J-F, Aleba, A, Orfeuvre, H, Agostini, C, Provencal, J, Ferrero, J M, Fric, D, Dohollou, N, Paraiso, D, Salvat, J, Pujade-Lauraine, É
Publicado 2009

Carbogen breathing increases prostate cancer oxygenation: a translational MRI study in murine xenografts and humans

por Alonzi, R, Padhani, A R, Maxwell, R J, Taylor, N J, Stirling, J J, Wilson, J I, d′Arcy, J A, Collins, D J, Saunders, M I, Hoskin, P J
Publicado 2009